Skip to Main Content

Over the last three years, John Flannery has transformed GE Healthcare.

He dragged a flat-lining business into the black. He reorganized staff to energize departments he thought had grown stagnant. He extended the company’s ability to support biologic drug manufacturing. And he poured more emphasis into emerging markets around the world.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.